Transmembrane Protein 166 and its Significance

Author(s): Yanwei Yang, Lingxue Zhou, Fushan Xue, Lixin An, Mu Jin, Li Li*

Journal Name: Protein & Peptide Letters

Volume 28 , Issue 4 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Transmembrane protein 166 (TMEM166) is a lysosomal/endoplasmic reticulum (ER)-associated protein found in different species where it functions as a regulator of programmed cell death through autophagy and apoptosis. It is expressed in a variety of normal tissues and organs, and it is involved in a wide variety of physiological and pathological processes, including cancers, infection, autoimmune diseases, and neurodegenerative diseases. Previous studies indicated that TMEM166 is associated with autophagosomal membrane development. TMEM166 can cause lysosomal membrane permeabilization (LMP) leading to the release of proteolytic enzymes, e.g., cathepsins, that may cause potential mitochondrial membrane damage, which triggers several autophagic and apoptotic events. A low level of TMEM166 expression is also found in tumors, while high level of TMEM166 is found in brain ischemia. In addition, loss of TMEM166 leads to impaired NSC self-renewal and differentiation along with a decrease in autophagy. These findings offer a comprehensive understanding of the pathways involved in the role of TMEM166 in programmed cell death and treatment of various diseases.

Keywords: TMEM166, autophagy, apoptosis, tumor, cerebral ischemia, embryonic neurogenesis.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 28
ISSUE: 4
Year: 2021
Page: [382 - 387]
Pages: 6
DOI: 10.2174/0929866527666201002150316
Price: $95

Article Metrics

PDF: 25